Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Dinney

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
The Journal of Urology|March 21, 1998
Timely delivery of biological therapy after cytoreductive nephrectomy in carefully selected patients with metastatic renal cell carcinomaD A Levy, D A Swanson, J W Slaton, et al.
The Journal of Urology|June 1, 1997
Risk of urethral, vaginal and cervical involvement in patients undergoing radical cystectomy for bladder cancer: results of a contemporary cystectomy series from M. D. Anderson Cancer CenterM E Chen, L L Pisters, A Malpica, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 1, 1995
Intravesical liposomal muramyl tripeptide phosphatidylethanolamine treatment of human bladder carcinoma growing in nude miceC P Dinney, S Tanguay, C D Bucana, et al.
British Journal of Cancer|May 2, 2013
Fluid intake, genetic variants of UDP-glucuronosyltransferases, and bladder cancer riskJ Wang, X Wu, A Kamat, et al.
Oncology Reports|August 10, 2001
Adenoviral-mediated gene therapy of human bladder cancer with antisense interleukin-8K Inoue, C G Wood, J W Slaton, et al.
Cancer|November 15, 1994
Preoperative radiotherapy for muscle-invasive bladder carcinoma. Long term follow-up and prognostic factors for 338 patientsA Pollack, G K Zagars, C P Dinney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2000
Gene therapy of human bladder cancer with adenovirus-mediated antisense basic fibroblast growth factorK Inoue, P Perrotte, C G Wood, et al.
Cancer Research|March 1, 1992
Immunotherapy of murine renal adenocarcinoma by systemic administration of liposomes containing the synthetic macrophage activator CGP 31362 or CGP 19835A in combination with interleukin 2 or gamma-interferonC P Dinney, T Utsugi, I J Fidler, et al.
Urology|April 1, 1994
Therapy and prognosis for male anterior urethral carcinoma: an updateC P Dinney, D E Johnson, D A Swanson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1997
Therapy of human transitional cell carcinoma of the bladder by oral administration of the epidermal growth factor receptor protein tyrosine kinase inhibitor 4,5-dianilinophthalimideC P Dinney, C Parker, Z Dong, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
The Journal of Urology|March 21, 1998
Timely delivery of biological therapy after cytoreductive nephrectomy in carefully selected patients with metastatic renal cell carcinomaD A Levy, D A Swanson, J W Slaton, et al.
The Journal of Urology|June 1, 1997
Risk of urethral, vaginal and cervical involvement in patients undergoing radical cystectomy for bladder cancer: results of a contemporary cystectomy series from M. D. Anderson Cancer CenterM E Chen, L L Pisters, A Malpica, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 1, 1995
Intravesical liposomal muramyl tripeptide phosphatidylethanolamine treatment of human bladder carcinoma growing in nude miceC P Dinney, S Tanguay, C D Bucana, et al.
British Journal of Cancer|May 2, 2013
Fluid intake, genetic variants of UDP-glucuronosyltransferases, and bladder cancer riskJ Wang, X Wu, A Kamat, et al.
Oncology Reports|August 10, 2001
Adenoviral-mediated gene therapy of human bladder cancer with antisense interleukin-8K Inoue, C G Wood, J W Slaton, et al.
Cancer|November 15, 1994
Preoperative radiotherapy for muscle-invasive bladder carcinoma. Long term follow-up and prognostic factors for 338 patientsA Pollack, G K Zagars, C P Dinney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2000
Gene therapy of human bladder cancer with adenovirus-mediated antisense basic fibroblast growth factorK Inoue, P Perrotte, C G Wood, et al.
Cancer Research|March 1, 1992
Immunotherapy of murine renal adenocarcinoma by systemic administration of liposomes containing the synthetic macrophage activator CGP 31362 or CGP 19835A in combination with interleukin 2 or gamma-interferonC P Dinney, T Utsugi, I J Fidler, et al.
Urology|April 1, 1994
Therapy and prognosis for male anterior urethral carcinoma: an updateC P Dinney, D E Johnson, D A Swanson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1997
Therapy of human transitional cell carcinoma of the bladder by oral administration of the epidermal growth factor receptor protein tyrosine kinase inhibitor 4,5-dianilinophthalimideC P Dinney, C Parker, Z Dong, et al.
Pageof 8